FDA Warns Against the Use of Drug Promoted as 'Cancer Cure'

The drug has not been evaluated or approved by the FDA to treat any disease
The drug has not been evaluated or approved by the FDA to treat any disease

The Food and Drug Administration (FDA) has warned against the purchase or use of PNC-27, a product marketed as a treatment or cure for cancer. A laboratory analysis found the presence of Variovorax paradoxus, a bacteria, in a solution sample for inhalation.

PNC-27 has not been evaluated or approved by the FDA as safe and effective to treat any disease. It is promoted as a tiny, nontoxic protein molecule that attaches to specific receptors only found on cancer cells, causing them to die. Individuals who use a contaminated product are at risk for serious, potentially life-threatening infections. Patient groups at greater risk include young children, the elderly, pregnant women, and the immunocompromised. 

Related Articles

PNC-27 is sold on the website PNC27.com and is supplied in different formulations, including a nebulized solution, intravenous solution, vaginal suppository, or rectal suppository. To date, the FDA has not received reports of illness or serious adverse events related to PNC-27.

For more information visit FDA.gov.